Boltz
About Boltz
Boltz develops frontier models and intelligent agents to accelerate drug discovery and reshape biology. They combine computational methods to enable hit identification, lead optimization, and protein design, with a focus on distributed screening and iterative refinement across large chemical spaces. Their work spans computational biology and medicinal chemistry, operating globally with resources like Boltz Lab for hands-on experimentation and collaboration. The company emphasizes building better molecules through AI-inspired approaches to accelerate biology-driven research.
Recent News
Boltz PBC Launches with $28M to Democratize AI Platforms for Drug Discovery
AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development
How Rootstock Distributes Rewards: Transparency and Fairness Explained
Boltz Raises $28M Seed to Build Open AI Models in Biology
Pharma Bets Big on AI Platforms with Flurry of New Year Deals
AWS Unveils Amazon Bio Discovery AI Platform to Accelerate Early‑Stage Drug Development